POINT Biopharma Global Inc. (PNT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate POINT Biopharma Global Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
7.01
Strong
WeakModerateStrong
P/B Ratio
1.42
Strong
WeakModerateStrong
Earnings Yield
14.25%
Strong
WeakModerateStrong
Profitability Health
2022Return on Equity
20.19%
Strong
WeakModerateStrong
Operating Margin
55.40%
Strong
WeakModerateStrong
Net Profit Margin
43.38%
Strong
WeakModerateStrong
Growth Indicators
2022Revenue Growth
-
No data
Net Income Growth
314.13%
Strong
WeakModerateStrong
EPS Growth
267.74%
Strong
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
6.66
Strong
WeakModerateStrong
Quick Ratio
6.66
Strong
WeakModerateStrong
Asset Turnover
0.39x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
24.76%
Strong
WeakModerateStrong
EV / Free Cash Flow
2.36x
Strong
WeakModerateStrong
Net Debt / EBITDA
-2.25x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.032
Strong
WeakModerateStrong
Return on Invested Capital
19.10%
Moderate
WeakModerateStrong
Cash Conversion Cycle
0.10 days
Moderate
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PNT.
View Financial Statements